Riskpilot← Back to searchSign inGet full accessDr Magnus Christensen AB
ABActiveOrg 5590889654Koltrastvägen 15 BMedical specialists activities · NACE 8622Est. 20160 employees
Revenue 2024
—
EBITDA margin
—
+4% vs 2023
Equity ratio
83.9%
Financial strength
Net profit 2024
SEK -6K
-362% vs 2023
| Revenue | — | — |
| EBITDA | SEK -6K | +4% |
| Net profit | SEK -6K | -362% |
| Total assets | SEK 83K | -8% |
| Equity | SEK 70K | -8% |
| Employees | 0 | — |
Legal name
Dr Magnus Christensen AB
Org number
5590889654
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
5 december 2016
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsult- och utbildningsverksamhet inom hälso- och sjukvård. Friskvård och rehabilitering. Föredrag och undervisning. Bemanningsverksamhet. Äga och förvalta fast och lös egendom inklusive fastigheter, handel med värdepapper samt därmed förenlig verksamhet.
Address
Koltrastvägen 15 B
Email
magnus@doktorchristensen.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | — | — |
| Staff expenses | — | — | — | — | — |
| EBITDA | −8 | −5 | −6 | −6 | −6 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −8 | −5 | −6 | −6 | −6 |
| Net financials | — | — | — | 0 | 0 |
| Profit before tax | 1 | 0 | −1 | −1 | −6 |
| Tax | −0 | −0 | — | — | — |
| Net profit | 1 | 0 | −1 | −1 | −6 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 112 | 106 | 96 | 90 | 83 |
| Equity | 79 | 79 | 77 | 76 | 70 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 19 | 17 | 14 | 14 | 13 |
| Total debt | 19 | 17 | 14 | 14 | 13 |
EBITDA margin
-620000.0%
This company
15.8%
Market median
-3924151% vs market
20202024
Equity ratio
83.9%
This company
38.2%
Market median
+120% vs market
20202024
Return on equity
-8.7%
This company
18.4%
Market median
-147% vs market
20202024
Net profit margin
-608600.0%
This company
8.1%
Market median
-7513680% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr Magnus Christensen AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Magnus Christensen | Board of Directors | 0 companies |
| Lilian Yvonne Alice Lowert | Deputy Board Member | 0 companies |